Delivery Order SPE2DB20D2104-SPE2DB25FMWTP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG capsules (30-count units) under a firm fixed-price contract. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count units) under a firm fixed price contract. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency (DLA) awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The contractor will perform under this order at its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of INGREZZA 80 mg capsules (30-count units) valued at $4,027.70. The contract utilizes firm fixed price terms with an ultimate completion date of October 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG capsules (30-count units) under a firm fixed price contract. The award, issued on August 25, 2025, with a completion date of September 16, 2025, represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,049.61 for INGREZZA 60 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) with a ceiling value of $7,352.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation and reflects the agency's procurement of...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWTPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG capsules (30-count packaging) with an ultimate completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The delivery order represents a routine pharmaceutical supply transaction consistent with the contractor's extensive portfolio of federal medical product deliveries to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/29/25 |